Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

477 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN.
Stegelmann F, Wille K, Busen H, Fuchs C, Schauer S, Sadjadian P, Becker T, Kolatzki V, Döhner H, Stadler R; German Study Group-MPN; Döhner K, Griesshammer M. Stegelmann F, et al. Among authors: schauer s. Leukemia. 2021 Feb;35(2):628-631. doi: 10.1038/s41375-020-0945-3. Epub 2020 Jul 3. Leukemia. 2021. PMID: 32616864 Free PMC article. No abstract available.
Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN.
Stegelmann F, Wille K, Busen H, Fuchs C, Schauer S, Sadjadian P, Becker T, Kolatzki V, Döhner H, Stadler R; German Study Group-MPN; Döhner K, Griesshammer M. Stegelmann F, et al. Among authors: schauer s. Leukemia. 2021 Dec;35(12):3635. doi: 10.1038/s41375-021-01366-3. Leukemia. 2021. PMID: 34785798 Free PMC article. No abstract available.
Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN).
Stegelmann F, Teichmann LL, Heidel FH, Crodel CC, Ernst T, Kreil S, Reiter A, Otten S, Schauer S, Körber RM, Kricheldorf K, Isfort S, Döhner H, Brümmendorf TH, Griesshammer M, Döhner K, Koschmieder S. Stegelmann F, et al. Among authors: schauer s. Leukemia. 2023 Apr;37(4):924-928. doi: 10.1038/s41375-023-01837-9. Epub 2023 Feb 24. Leukemia. 2023. PMID: 36828867 Free PMC article. No abstract available.
DNMT3A mutations in myeloproliferative neoplasms.
Stegelmann F, Bullinger L, Schlenk RF, Paschka P, Griesshammer M, Blersch C, Kuhn S, Schauer S, Döhner H, Döhner K. Stegelmann F, et al. Among authors: schauer s. Leukemia. 2011 Jul;25(7):1217-9. doi: 10.1038/leu.2011.77. Epub 2011 May 3. Leukemia. 2011. PMID: 21537334 No abstract available.
Association Between Neuromuscular Blocking Agents and Outcomes of Emergency Tracheal Intubation: A Secondary Analysis of Randomized Trials.
DeMasi SC, Self WH, Aggarawal NR, April MD, Andrea L, Barnes CR, Brainard J, Blinder V, Dagan A, Driver B, Doerschug KC, Douglas I, Exline M, Fein DG, Gaillard JP, Gandotra S, Gibbs KW, Ginde AA, Halliday SJ, Han JH, Herbert T, High K, Hughes CG, Khan A, Latimer AJ, Maiga AW, Mitchell SH, Muhs AL, Mohamed A, Moskowitz A, Page DB, Palakshappa JA, Prekker ME, Qian ET, Resnick-Ault D, Rice TW, Russel DW, Schauer SG, Seitz KP, Shapiro NI, Smith LM, Sottile P, Stempek S, Trent SA, Vonderhaar DJ, Walker JE, Wang L, Whitson MR, Casey JD, Semler MW; Pragmatic Critical Care Research Group. DeMasi SC, et al. Among authors: schauer sg. Ann Emerg Med. 2024 Oct 8:S0196-0644(24)00962-4. doi: 10.1016/j.annemergmed.2024.08.509. Online ahead of print. Ann Emerg Med. 2024. PMID: 39387758 Free article.
477 results